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Abstract Background: Strokes 
occur in sickle cell disease (SCD), 
and are associated with significant 
morbidity and mortality. 
Objectives: To determine the 
prevalence of strokes amongst chil-
dren with SCD, and document the 
major clinical features, complica-
tions, effect of treatment with 
chronic transfusion therapy (CTT) 
and outcome.  
Methods: A descriptive retrospec-
tive study of SCD children with 
strokes seen at the National Hospi-
tal Abuja, Nigeria over a 2.5 year 
period from January 2009 – June 
2012. Data was collected by scruti-
nizing case files obtained from the 
hospital medical records unit. In-
formation obtained included demo-
graphic data, clinical features, 
packed cell volume (PCV), brain 
imaging, long term neurologic 
deficits, effect of CTT, stroke re-
currence and outcome. 
Results: There were 31 children 
with strokes among 596 children 
with SCD documented in the regis-
ter, giving a prevalence of 5.2%. 
Twenty six (26) case notes were 
retrieved.  There were 12 males 
and 14 females, M: F ratio of 0.9:1; 
mean age was 6.4 years (SD 3.4) 
range: 1 year 7 months – 14 years; 
mean PCV at the time of strokes 
was 21.1% (SD 3.9) range 14 – 
29%. All (100%) had Haemoglobin 
SS on electrophoresis. Presenta-
tions were convulsions 18, inability 
to use limbs 11, weakness of limbs 
10; long term neurological deficits 
were hemiplegia 11, cognition loss 11. 
Three (3) children had no deficits.  
Brain imaging (Computed Tomogra-
phy Scan and Magnetic Resonance 
Imaging) done in 16 (61.5%) children 
showed cerebral atrophy in 10, 
acute cerebral infarcts in 9, chronic 
cerebral infarcts in 6, acute intra 
cranial haemorrhage in 1 and nor-
mal imagings in 4 children.  
Twelve (12) children (46.2%) chil-
dren had recurrences of stroke rang-
ing in number from 1 to 4, which 
occurred 6 months to 3 years after 
the initial stroke. There were no 
statistical significant differences 
between the children with recur-
rences of stroke compared to those 
without regarding the age, sex, 
weight or PCVs   p > 0.05. 
Fifteen (15) children (57.7%) were 
enrolled in CTT. Two (2) out of 7 
children (28.6%) that had regular 
CTT had stroke recurrence; com-
pared to 5 out of 11 children 
(45.4%) with no CTT (p > 0.05). 
Four (4) out of 6 (66.7%) children 
with irregular CTT and 1 of 2 chil-
dren who stopped CTT had stroke 
recurrence.  
Outcome: 17 children were alive, 7 
were lost to follow up, 1 died and 1 
was referred to another center. 
Conclusion: Strokes were an impor-
tant cause of morbidity in Nigerian 
children with SCD, with major long 
term neurologic deficits. CTT ap-
peared beneficial in preventing 
stroke recurrences. Primary preven-
tion strategy by Trans Cranial Dop-
pler ultrasound studies of the cere-
bral arteries, with the aim of 
promptly initiating appropriate preven-
tive therapy for stroke is strongly advo-
cated. 
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Introduction   
 
Strokes (cerebrovascular accidents CVA) are potentially 
devastating consequences of sickle cell disease (SCD), 
which have been associated with significant morbidity 
and mortality. 1   
The reported risk of a first stroke in SCD is up to 0.85 
per 100 patient years in the first 20 years of life, 1 - 5 with 
a prevalence of up to 11.5%. 1 – 9  Recurrence rates of 
14% 6 - 61.5% 1, 3, 5 – 7, 9 have been reported from devel-
oped and developing countries including Nigeria respec-
tively.  They commonly occur in children up to 14 years 
of age1 – 7, 9 -10  in all forms of SCD, with the highest inci-
dences in sickle cell anaemia. 1 -3, 5 - 7   Deaths 1 – 6, 8 – 10   
and debilitating neurological sequels to the growing 
child such as cognition loss, motor and sensory deficits, 
learning difficulties, psychological and emotional prob-
lems as well as seizure disorders have been recorded 
after the first stroke.1, 6 – 7, 9, 11 – 13  
The aim of this study was to determine the prevalence of 
strokes amongst our patients with SCD, describe its 
clinical features, haematocrit levels on admission, radio-
logical brain imaging, neurological deficits, recurrences, 
effect of management with chronic blood transfusion 
therapy (CTT), and the outcome of these children. It is
hoped that this information will increase the awareness 
to strokes in SCD, and the use of Trans Cranial Doppler 
(TCD) ultrasound studies of the cerebral vessels as a 
primary prevention screening tool for strokes in SCD.6 – 
7, 14 This is important particularly in low resource coun-
tries of the world such as ours where TCD studies ar  




Materials and methods  
 
This is a descriptive retrospective study of children with 
SCD seen at the paediatric unit of the National Hospital 
Abuja, a referral center located in the capital city of Ni-
geria over a 2.5 year period from January 2009 – June 
2012. The hospital provides tertiary level health care and 
receives patients from both its immediate environs a d
surrounding cities.  The paediatric unit of the hospital 
has facilities for emergency paediatric care, inpatient 
admissions, newborn care and outpatient specialist clin-
ics; which includes a weekly sickle cell clinic.  
All children attending the sickle cell clinic had their 
haemoglobin genotype determined by cellulose acetate 
haemoglobin electrophoresis methods carried out by the 
Haematology unit of the hospital.  
 
Medical notes of children with SCD who had strokes 
were retrieved from the medical records department and 
the following information obtained: demographic data, 
clinical features, packed cell volume (PCV), and raio-
logical brain imaging as at the time of the stroke. Infor-
mation on long term neurologic deficits (if any), man-
agement with chronic blood transfusion therapy (CTT), 
recurrence of strokes and their outcome was also  
obtained. 
 
A stroke was defined as an acute neurologic syndrome 
secondary to occlusion of a cerebral artery or haemor-
rhage with resultant ischaemia and neurologic signs and 
symptoms lasting greater than 24 hours.1 These were 
infarctive and/or haemorrhagic strokes based on avail-
able clinical and neuro imaging studies of Computed 
Tomographic (CT) scan and/or Magnetic Resonance 
Imaging (MRI) of the brain.  
 
Children with SCD attending the clinic received a st n-
dard of care according to the unit policy. This comprised 
SCD genetic counseling of the caregivers and child (as 
was appropriate for age); counseling for immunizations 
and nutrition, information on how to prevent and iden-
tify crises and early management of same; as well as 
regular growth monitoring, clinical evaluations, PCV 
assessments, folic acid supplementation and malaria 
chemo prophylaxis; and additional Pneumococcal and 
Haemophilus B Influenza immunizations. In addition, 
they received an information booklet on SCD. There 
were facilities available for prompt management of ill-
nesses and complications, emergency admissions, blood 
transfusions, and exchange blood transfusions. The chil-
dren could be seen at any time at the Emergency Paedi-
atric Unit.  
 
Children with strokes were seen for follow up in the 
clinic, and after parental counseling offered chronic 
transfusion therapy (CTT) - blood transfusions on a 
monthly basis (every 4 weeks). The aim of CTT was to 
keep the PCV > 30% and the haemoglobin S < 30%, 6  
which is a secondary preventive measure for strokes in 
SCD. We were however unable to routinely assess the 
Hb S% in them. Packed red blood cell transfusions 
(haemoglobin genotype AA) were given as required an 
the volumes determined by the formula [(Desired Hb - 
Actual Hb) x Weight (kg) x 3], according to the unit 
policy. Post transfusion PCVs were determined after 48 
– 72 hours. The children had their serum iron studies 
assessed and iron chelating therapy prescribed as re-
quired. Hydroxyurea starting at 15mg/kg and increasing 
to 30mg/kg was given to all the children with strokes 
after parental counseling. This drug was closely moni-
tored for side effects by 2 monthly complete blood 
counts, liver and kidney function tests. Other supportive 
therapy as required for rehabilitation such as physiother-
apy, speech therapy, hearing aids, anti convulsant ther-
apy were provided in association with the appropriate 
specialist departments.    
 
The results were presented as simple frequencies and 
percentages and shown in tables. Descriptive statistics 
were expressed as means +/- 2 standard deviations. Sta-
tistical evaluations were done by Microsoft Excel 2007 
and Statistical Package for Social Sciences SPSS ver-
sion 16. Associations between variables were done by 
the chi square test as appropriate. A p value of less than 
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Results 
 
There were 31 children with strokes among the 596 chil-
dren with SCD seen in the paediatric unit, giving a 
prevalence of 5.2%. Twenty six (26) case notes were 
retrieved and the data is presented. There were 12 males 
and 14 females, M: F ratio of 0.9:1; mean age was 6.4 
years (SD 3.4), age range 1 year 7 months – 14 years. 
The mean duration of follow up was 2.8 years (SD 1.4), 
range 0.4 – 6 years. The packed cell volumes (PCV) at 
the time of the strokes ranged from 14 – 29%, with a 
mean of 21.1% (SD 3.9). The mean expected weight for 
age according to the modified Wellcome classification 
was 96.3% with a range of 76.6 – 122%.  There were 22 
(84.6%) children with normal weight (80 – 120% ex-
pected weight for age), and 2 (7.7%) children each wit
under nutrition (60 - < 80% expected weight for age) 
and over nutrition (> 120% expected weight for age) 
respectively. All (100%) the children had Haemoglobin 
SS (sicke cell anemia) on Haemoglobin electrophoresis. 
Clinical presentations were: convulsions in 18, inab lity 
to use limbs in 11, and weakness of parts of the body in 
10, coma in 7 and headaches in 5 children respectively 
(Table 1). Long term neurological deficits observed dur-
ing follow up were: hemiplegia and cognition loss 11
children each, aphasia in 8 children, facial nerve palsy in 
7 children, and swallowing incoordination in 5 children. 
Three (3) children had no long term neurological deficits 
(Table 2).  
 
Table 1: Presenting clinical features found in 26 children with 
SCD and stroke  
Others 1 (3.8%) each of unsteady gait and dizziness  
 
Table 2: Long term neurological deficits in 26 children with 
SCD and stroke  
Others 1 (3.8%) each of behavioural disorder, learning disability and 
deafness.  ADHD - Attention Deficit Hyperactivity Disorder    
Presentations n = 26 Frequency (%) 
Convulsions 18 (69.2%) 
Inability to use limbs 11 (42.3%) 
Weakness of limbs 10 (38.5%) 
Coma 7 (26.9%) 
Headaches 5 (19.2%) 
Fever 4 (15.4%) 
Inability to talk 3 (11.5%) 
Slurred speech 3 (11.5%) 
Inability to see 2 (7.7%) 
Others 2 (7.7%) 
Long term Neurological deficits   n = 26 Frequency (%) 
Cognition loss 11 (42.3%) 
Hemiplegia 11 (42.3%) 
Aphasia 8 (30.8%) 
Hemipareisis 8 (30.8%) 
Facial nerve palsy 7 (26.9%) 
Swallowing incordination 5 (19.2%) 
Seizure disorder 3 (11.5 
Slurred speech 2 (7.7%) 
Urinary/Faecal incontinence 2 (7.7%) 
Quadriplegia 2 (7.7%) 
ADHD 2 (7.7%) 
None 3 (11.5%) 
Others 3 (11.5%) 
There were 17 (65.4%) radiological brain imaging stud-
ies done in 16 children; 8 Computed Tomography (CT) 
Scans, and nine Magnetic Resonance Imagings (MRI) 
(Table 3). Ten (38.5%) children had no brain imaging 
study done. The imaging studies were done in the acute 
phase - first 72 hours and up to a week after the sroke 
event. These brain imagings showed cerebral atrophy 
(Fig 1) in 10 children, acute cerebral infarcts (Fig 2) in 
nine children, chronic cerebral infarcts in six children 
and intra cranial haemorrhage in one child (Fig 3). The 
child with the intracranial haemorrhage had the CT scan 
done 48 hours after the stroke.  There were four normal 
brain imagings. One child had two CT scans of the 
brain; the initial scan was normal, while the scan ob-
tained after the second stroke three years later was ab-
normal, showing multiple old and new infarcts.   
 
Table 3: Radiological imaging (CT scan and MRI brain) in 16 
children with SCD and stroke 




7 years, male MRI brain: T2 
FLAIR MRI brain 
(Transverse plane) 
• Wedge shaped area of 
hypo intensity in the right 
frontal lobe and prominence 
of the adjacent cerebral 
sulci - cerebral infarction  
• Prominence of the 
right Sylvian fissure and 
inter hemispheric fissure, 
dilatation of the frontal horn 
of the right lateral ventricle           
    – porencephalic cyst 
 
Fig 2  
 
7 years, male MRI brain: T2 
FLAIR MRI brain 
(Transverse plane) 
• T2 weighted MRI of the 
brain in transverse plane 
showing cerebral atrophy of 
the right cerebral hemisphere 
 
CT/MRI brain findings    n = 17* Frequency (%) 
Cerebral atrophy 10 (58.8%) 
Acute cerebral infarcts 9 (52.9%) 
Chronic cerebral infarcts 6 (35.3%) 
Acute ischaemic changes 4 (23.5%) 
Acute cerebral bleed 1 (5.9%) 
Porencephalic cyst 1 (5.9%) 
Normal 4 (23.5%) 
   160 
Fig 3 
 
10 years, female MRI brain: T2 
FLAIR MRI brain (Transverse 
plane) 
• Hypo intense areas consis-
tent with intra ventricular 
bleed/hemorrhage in both bod-
ies of the lateral ventricles 
worse on the left side;  
• Dilatation of the left lat-
eral ventricle with resultant 
atrophy of the adjacent cerebral 
cortex  
 
Twelve children (46.2%) children had recurrences of 
stroke ranging in number from one to four, which oc-
curred from six months to three years after the initial 
stroke. There were no statistical significant differences 
between the children with recurrences of stroke com-
pared to those without recurrence regarding the age, sex, 
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weight, or PCV (Table 4). 
Fifteen (57.7%) children were enrolled in a monthly 
chronic blood transfusion therapy (CTT, hyper transfu-
sion) programme, a standard of care for children with 
SCD who have had strokes6, while 11 children (42.3%) 
were not (Table 4). These transfusions had been given 
for a period of four months to three years, eight months 
at the time of writing. Of the seven children with regular 
blood transfusions, five (71.4%) had no recurrence of 
stroke while two (28.6%) did. Four (66.7%) of six chil-
dren on irregular CTT as well as five of the 11 (45.4%) 
children not on blood transfusions had recurrences of 
strokes. These differences were not statistically signifi-
cant p > 0.05 (Table 4). Two children – an 11 year old 
girl and a 10 year old boy stopped the transfusions after 
8months and one year, five months respectively. The
girl had a recurrence of stroke after three years, while 
the boy did not have a recurrence of stroke in 4 years of 
follow up.  
Table 4: Demographic features, PCV values, effect of chronic transfusion therapy, and outcomes on recurrence of str ke in 26 
children with SCD   
2 children commenced blood transfusion therapy after th  2nd stroke 
a The children with the unknown PCV at the time of stroke had been transfused prior to arrival at the hospital 
CTT – Chronic transfusion therapy: - Regular: Monthly blood transfusions as required; Stopped: No blood transfusions for more 
than 4 consecutive months; Irregular: Irregular blood transfusions but not for up to 4 consecutive months in between transfusions 
Regarding outcome at the time of writing, 17 (65.4%) of 
the children were alive, 7 (26.9%) were lost to follow 
up, 1 had died, while 1 was referred to another centre 
(Table 4). The 17 children who are alive are been fol-
lowed up in our clinic and are receiving, in addition to 
standard care for SCD offered at our center, rehabilita-
tion by physiotherapy, speech therapy, hearing aids, nd 
other medications such as anti-convulsants as required. 
Two children attend special schools for the mentally 
handicapped and for children with special needs  
respectively. Another child was taken out of regular 
school due to persistently poor performance, and a 4th 
child who is wheel chair bound attends a regular school. 
An 8 year old girl died during a recurrent stroke episode 
at the hospital, while the referral was due to relocation 






The 5.2% prevalence of strokes amongst our patients 
with SCD is higher than 4.01% reported from the Coop-
erative Study of Sickle Cell Disease (CSSD), 1 though 
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lower than previous reports of 7.8% from the Jamaican 
cohort study of SCD, 2 and 11.5% reported from the 
Dallas cohort study of SCD.5 It is however similar to 
recent previous reports of up to 5.4% from Nigeria by 
Ahmed 8 and Fatunde 9 though much higher than <1% 
previously reported by Izuorah 11 and Akinyanju15 3 
decades earlier.   All the children had sickle cell anaemia 
and the age range was similar to previous reports with 
majority of the children being below 10 years of age.1-5    
Low steady state haemoglobin concentration and acute 
decreases in the steady state haematocrit have been iden-
tified as risk factors for strokes in SCD. 1,2,6, 7, 14   About 
a quarter of the children of this study had PCV of less 
than 25% at the time of the stroke.  The significance of 
this finding as a possible risk factor for stroke in this 
study could not be ascertained. We  were not privy to 
the steady state haematocrit levels of the children and 
could therefore not determine if this represented acute 
decreases in steady state haematocrit or not.  Thiswas a 
limitation of the study.  
 
The clinical features at time of stroke such as convul-
sions, weakness of parts of the body, inability to use the 
limbs, headaches and coma have been previously re-
ported as are the varying long term neurological deficits 
of hemiplegia, aphasia and facial nerve palsy recorded in 
this study.2,3, 6–9, 11-13, 16 While these manifestations are in 
consonance with most previous studies, 6-7, 11, 13, 16 a 
striking feature in the present study is the cognitio  loss 
in over 50% of the patients. Severe deficits like quadri-
plegia, deafness and swallowing in-coordination were 
also among those observed. These have enormous sig-
nificance, emphasizing the loss of the ability of these 
children to attain their true potentials and live a normal 
quality of life. The need for particular investigations 
such as radiological brain imagings, and various forms 
of rehabilitation including physiotherapy, special 
schools, special care givers, medications, speech therapy 
and hearing aids increases the cost of care of these chil-
dren and constitute a burden to the family and society. 
Of note are the three children with clinical and raio-
logical features of strokes, and no long term neurologi-
cal deficit. Such occurrences have been previously re-
ported in literature.1, 6 – 7,13 Associations of the location 
and volume of anatomical sites of CNS infarcts with 
specific areas of neurocognitive dysfunction have be n 
described by Kirkham, Schatz and others, in defining the 
type and magnitude of neurological sequelae in stroke.6 – 
7, 17 - 18 Thus, when the site of the cerebral infarcts occurs 
in non motor areas of the brain, there may be minimal or 
no motor deficits, although subtle neuro cognitive dys-
functions may appear in the future.7, 17,18 
 
It was not possible to have radiological imagings for all 
the children in the study. This was due to the costof the 
investigations which could not be afforded by some of 
the care givers. This highlights the need for health insur-
ance in low resource countries with wide spread poverty 
or appropriate increase in government funding to cater 
for the health needs of her people. The findings from 
radiological imaging done at the time of stroke among 
our patients were similar to those reported from the
CSSD and other studies,1,6-7, 19 – 22 with infarctive strokes 
occurring more commonly than haemorrhagic strokes.   
We were unable to do magnetic resonance angiography 
or other arteriogram as was done in these studies just 
alluded to, which would have yielded further informa-
tion. Cerebral haemorrhages are uncommon in children 
with SCD during a stroke 1, 6 - 7 and only one of the chil-
dren who had brain imaging in this study had this fea-
ture, similar to the CSSD.1 It is also noteworthy that four 
children in this study had normal brain imagings depite 
the clinical features of strokes. It is likely that in these 
children so referred to, the investigations were done 
quite early in the course of the stroke before the radio-
logical changes could be recorded by the brain imagng 
techniques available at the hospital. It has been docu-
mented that CT scans may not show abnormalities 
within the first 24 hours of a stroke, whereas diffusion-
weighted and T2 weighted MRI may show ischaemic 
changes and haemorrhages within the immediate 1 - 3 
hours of the event.6 - 7,20 - 22 We also had children with 
brain imagings done during the acute stroke event that 
showed evidence of chronic cerebral infarcts, thus 
strengthening the suggestion of previous silent infarcts 
(brain infarction on imaging studies in the absence of 
neurologic symptoms). 1, 6 -7, 21 - 22 This underscores the 
importance of Trans Cranial Doppler (TCD) studies of 
the cerebral vessels as a screening tool to identify chil-
dren with SCD at high risk of stroke and commence 
therapy for primary prevention of strokes.6 – 7, 14 This 
therapy comprises regular blood transfusions intended to 
reduce the Hb S concentration to < 30% when there are 
abnormally high blood flow velocities of the cerebral 
arteries on TCD studies. This recommendation is based 
on the results of the Stroke Prevention Trial in Sickle 
Cell Anaemia (STOP) 14 study that showed a clear bene-
fit for prophylactic transfusions in preventing stroke in 
these children. 6,7  
 
Strokes in children with SCD have been reported to re-
cur in up to 14% of cases in developed countries, while 
in developing countries the recurrence of 61% is much 
higher.1, 3, 5,6,7, 9  We had a recurrence rate of 42%, which 
was higher than has been previously reported for devel-
oped countries, but similar to studies from Nigeria and 
other developing countries. 1, 3, 5 – 7, 9 The difference in 
recurrence rates between the developed and developing 
countries could be attributed to better health care in the 
developed countries of the world and the use of the hy-
per transfusion programmes, which is not done routinely 
in most developing countries. 11  It has also been sug-
gested that there might be some genetic or environ-
mental factors responsible for this difference.6-7, 24   
 
Chronic Transfusion Therapy CTT  (hyper transfusion 
programs) to keep the PCV > 30% and the Hb S concen-
tration < 30% are the standard of care to prevent scon-
dary recurrence of strokes in SCD, reducing the risk
from approximately 67% to  less than 10% .6 -7  Some 
caregivers in the present study refused this form of treat-
ment despite counseling . We had difficulties maintain-
ing the blood transfusions over the period of this report, 
as well as managing the ensuing complications that 
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arose, such as non availability of blood as required, 
transfusion related costs and iron overload. Majority 
(71.4%) of the children receiving CTT in this study id 
not have recurrence of strokes; in comparison to about 
45% of the children who never received these transfu-
sions that had stroke recurrences.  These findings are 
similar to what was reported by Adams6 and Kirkland.7  
The recurrence of strokes despite regular blood transfu-
sions in SCD as found in this study have been previ-
ously reported.6, 7, and 24 It was suggested that although 
chronic transfusions can reduce the risk of having a re-
currence of stroke, it cannot completely eliminate it.6 
Moyamoya disease, the formation of a mass of small 
friable blood vessels in response to severe stenosis or 
occlusion of major intracranial vessels, frequently seen 
in SCD, has been identified as a risk factor for stroke 
recurrence despite regular transfusion.6, 7, 24 - 25 These 
blood vessels, which have a propensity to rupture, may 
be responsible for the occurrence of frequent strokes. 
Indeed, recurrent infarctions have been reported to be  
more likely to occur in children with moyamoya syn-
drome.7 Furthermore, we had one child who stopped 
CTT, as well as the 6 children who never had CTT who 
had no recurrence of strokes in the follow up period. 
These children, who were not on CTT, had been receiv-
ing the drug hydroxyurea. Similar experiences have 
been documented elsewhere 6,7,26 and indeed hydroxy-
urea has been suggested as an alternative treatment o 
CTT in the secondary prevention of strokes in SCD. 6,7 
Despite the fact that the small sample size in this study 
makes any definitive statement about usefulness of CTT
(hyper transfusion programme) difficult, it does seem to 
have been beneficial in preventing recurrence of str kes 






We found that strokes occur with a prevalence of 5.2% 
and constitute an important cause of morbidity in SCD 
patients in Abuja, Nigeria, with convulsions being the
commonest presenting feature and hemiplegia and cog-
nition loss the most commonly encountered long term 
neurological deficits. It was also noted that chronic 
transfusion therapy (hyper transfusion programme) did 
seem beneficial in preventing stroke recurrences in these 
patients.  It is advocated that primary prevention of 
strokes by Transcranial Doppler studies of the cerebral 
arteries14 as a screening tool be done on regular basis in 
children with SCD so as to initiate preventive measure  
as deemed appropriate. 
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